Mouraviev, "Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: implications for unilateral ablative therapy," Prostate, vol. 68, no. 13, pp. 1380- 1386, 2008.Polascik TJ, Mayes JM, Sun L, Madden JF, Moul JW, Mouraviev V. Pathologic stage T2a ...
Brachytherapy is an excellent definitive treatment modality for select patients with localized prostate cancer. Sixty-four patients with Stage T2a prostate adenocarcinoma were identified from the series of prostate patients receiving conformal outpatient brachytherapy between 1990 and 1997. Pretreatment Gleason ...
All patients had clinically localized prostate cancer (PCa) and underwent radical prostatectomy (RP) at a single institution between 1988 and 2006. The authors focused on the inves tigation of epidemiologic trends in pathologic features, such as the pT stage, pathologic Gleason score, and percent ...
Brachytherapy is an excellent definitive treatment modality for select patients with localized prostate cancer. Sixty-four patients with Stage T2a prostate adenocarcinoma were identified from the series of prostate patients receiving conformal outpatient brachytherapy between 1990 and 1997. Pretreatment Gleason ...